It requires adequate stomach acid, intrinsic factor production, and healthy intestinal absorption
Use: To reduce the risk of sustained decline in eGFR, end-stage kidney disease, cardiovascular death, and hospitalization in adults with chronic kidney disease that is at risk of progression
Both are spaced 36 weeks apart to allow full tissue response between treatments
The table below summarizes clinical characteristics, typical dosing ranges, and common considerations for semaglutide and tirzepatide
Providers typically schedule follow-up appointments to assess response, adjust dosing, monitor for adverse effects, and evaluate whether continued treatment remains appropriate
Therefore, we analyzed a sub-G1 cell population using flow cytometry with PI staining to calculate the percentage of apoptotic cells